A Post-Authorization, Long-term Study of Ozanimod Real-world Safety

Clinical trial NCT05605782 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05605782
Sponsor: Bristol-Myers Squibb
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2021-09-02
Primary completion: 2033-07-26
Enrollment: 9000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.